Enveric Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Enveric Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q4 2024.
  • Enveric Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 503K shares, a 249% increase year-over-year.
  • Enveric Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 503K shares, a 249% increase from 2023.
  • Enveric Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 144K shares, a 90% decline from 2022.
  • Enveric Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.45M shares, a 206% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 503K +359K +249% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 8.7M +6.54M +302% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 7.59M +5.48M +260% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 4M +1.92M +92.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 144K -1.3M -90% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 2.16M +377K +21.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 2.11M +1.05M +100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 2.08M +1.23M +145% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 1.45M +974K +206% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 1.79M +1.33M +289% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 1.05M +627K +147% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 847K -15.4M -94.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 472K -5.28M -91.8% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
Q3 2021 459K -4.83M -91.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 427K -3.09M -87.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 16.2M +10.6M +187% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 5.75M +466K +8.82% Oct 1, 2020 Dec 31, 2020 10-K 2021-04-01
Q3 2020 5.29M +3.18M +150% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q2 2020 3.52M +1.49M +73.6% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 5.65M +3.85M +213% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 5.29M +4.34M +456% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 2.11M -19.5M -90.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 2.03M -16.8M -89.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 1.81M -16.8M -90.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 952K -14M -93.6% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 21.7M +6.94M +47.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 18.8M +4.18M +28.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 18.7M +4.56M +32.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 15M +1.91M +14.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 14.7M +1.06M +7.78% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 14.6M +1.77M +13.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 14.1M +2.22M +18.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 13.1M +1.97M +17.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 13.7M +3.66M +36.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 12.8M +1.21M +10.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 11.9M +1.88M +18.8% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-15
Q4 2015 11.1M -4.14M -27.2% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 9.99M -5.42M -35.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 11.6M +1.65M +16.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 9.99M -4.91M -32.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 15.2M +3.1M +25.5% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-31
Q3 2014 15.4M +3.27M +26.9% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 9.99M -2.15M -17.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-18
Q1 2014 14.9M +2.76M +22.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 12.1M 0 0% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 12.1M 0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 12.1M 0 0% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 12.1M 0 0% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-08
Q4 2012 12.1M +3.68M +43.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 12.1M +3.66M +43.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 12.1M +5.64M +86.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 12.1M +5.64M +86.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 8.46M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 8.48M +1.98M +30.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 6.5M 0 0% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 6.5M Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-10
Q3 2010 6.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 6.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.